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Abstract: Reviews of national and state-specific cancer registries have revealed differences in rates
of oral, esophageal, and lung cancer incidence and mortality that have implications for public
health research and policy. Many significant associations between these types of cancers and major
risk factors, such as cigarette usage, may be influenced by public health policy such as smoking
restrictions and bans—including the Nevada Clean Indoor Air Act (NCIAA) of 2006 (and subsequent
modification in 2011). Although evaluation of general and regional advances in public policy
have been previously evaluated, no recent studies have focused specifically on the changes to the
epidemiology of oral and pharyngeal, esophageal, and lung cancer incidence and mortality in Nevada.
Methods: Cancer incidence and mortality rate data were obtained from the National Cancer Institute
(NCI) Division of Cancer Control and Population Sciences (DCCPS) Surveillance, Epidemiology
and End Results (SEER) program. Most recently available rate changes in cancer incidence and
mortality for Nevada included the years 2012–2016 and are age-adjusted to the year 2000 standard
US population. This analysis revealed that the overall rates of incidence and mortality from these
types of cancer in Nevada differs from that observed in the overall US population. For example,
although the incidence rate of oral cancer is decreasing in the US overall (0.9%), it is stable in Nevada
(0.0%). However, the incidence and mortality rates from esophageal cancer are also decreasing in
the US (−1.1%, −1.2%, respectively), and are declining more rapidly in Nevada (−1.5%, −1.9%,
respectively). Similarly, the incidence and mortality rates from lung are cancer are declining in the
US (−2.5%, −2.4%, respectively) and are also declining more rapidly in Nevada (−3.2%, −3.1%,
respectively). Analysis of previous epidemiologic data from Nevada (1999–2003) revealed the highest
annual percent change (APC) in oral cancer incidence in the US was observed in Nevada (+4.6%),
which corresponded with the highest APC in oral cancer mortality (+4.6%). Subsequent studies
regarding reduced rates of cigarette use due to smoking restrictions and bans have suggested that
follow up studies may reveal changes in the incidence and mortality rates of oral and other related
cancers. This study analysis revealed that oral cancer incidence rates are no longer increasing in
Nevada and that mortality rates have started to decline, although not as rapidly as the overall
national rates. However, rapid decreases in both the incidence and mortality from esophageal and
lung cancer were observed in Nevada, which strongly suggest the corresponding changes in oral
cancer may be part of a larger epidemiologic shift resulting from improved public health policies that
include indoor smoking restrictions and bans.
Keywords: oral cancer; epidemiology; incidence; mortality; Nevada
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1. Introduction
Reviews of national and state-specific cancer registries have revealed many differences
in oral and pharyngeal cancer incidence and mortality that have profound implications
for public health research and policy [1,2]. For example, some studies have revealed
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divergent trends in oral cancer incidence based on regional differences in socioeconomic
demographics [3]. Other research has confirmed these associations and has provided
more specific details evaluating shared risk factors, which may contribute to these regional
differences [4].
Regional and state-level analyses have revealed many significant associations between
oral and pharyngeal cancers with major risk factors, such as cigarette usage, that may
also be influenced by public health policy such as smoking restrictions and bans [5,6].
For example, recent changes to smoke-free workplace policies and other smoking bans
have resulted in significant changes in cigarette usage, as well as secondhand smoke
exposures [7,8]. Studies of the results of these changes were used as justification in 2011
to modify and expand the Nevada Clean Indoor Air Act (NCIAA), which was originally
passed in 2006 to reduce primary usage of cigarettes and tobacco products in public places
and to reduce secondhand smoke exposure [9,10].
The NCIAA was designed to protect both children and adults from cigarette smoke
and second-hand cigarette smoke in the majority of public spaces and places of employment [11]. The overall goal of this legislation was to reduce the availability of, and provide disincentives towards, cigarette smoking and to reduce the environmental effects of
smoking-related aerosols including second-hand smoke, from public and private school
buildings, childcare facilities, grocery and drug stores, indoor restaurants and shopping or
retail establishments, video arcades, movie theaters and government buildings—although
some casino gaming areas were exempted [12]. Modification of these protocols was made
to include vaping and e-cigarettes in 2011, with evaluations of air quality and particulate
matter from casino non-smoking areas demonstrating significant reductions in smoking
related aerosols and particulate matter (PM2.5) compared with smoking areas, R = 0.71,
p = 0.005 [13], which may lead to improved public health and reductions in smokingrelated cancers.
Although evaluation of general and regional advances in public policies around
smoking have been evaluated, no recent studies have focused specifically on the evaluation
of the effects of these changes to related cancer incidence and mortality in Nevada, such as
oral, esophageal and lung cancers. To date, only two studies (both published more than ten
years ago) have evaluated these trends in oral cancers in Nevada, which may have changed
significantly in the intervening decade [14,15]. Based upon the lack of recent analysis and
epidemiologic data, the primary objective of this study was to evaluate the recent changes
to the epidemiology of both rates of incidence of, and mortality from these smoking-related
cancers in Nevada.
2. Materials and Methods
2.1. Source Data and Analysis
Cancer incidence and mortality data for this study were obtained from the National
Cancer Institute (NCI) Division of Cancer Control and Population Sciences (DCCPS)
Surveillance, Epidemiology and End Results (SEER) program [16]. This program collects incidence and survival data from approximately 34.6% of the United States (US)
population designed for public use and dissemination [17]. These data are compiled
through the National Center for Health Statistics (NCHS), which evaluated and compiled
data regarding cancers of the oral cavity and pharynx.
The US and Nevada oral and pharyngeal, esophageal, and lung cancer incidence and
mortality statistics in this study were generated using the SEER database program (NCHS,
Hyattsville, MD, USA) (SEER*Stat). Methods used to determine rates and trends have been
previously reported [15]. In brief, these data are obtained from the National Vital Statistics
System public use data files and are compiled and analyzed by the NCHS using the Join
point Trend Analysis statistical software. This program evaluates and models the natural
logarithm of any selected incidence or mortality rate, provides identification of the years
during which any observed changes in trend are noted, and provides summary statistics or
graphics, based upon this analysis.
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Figure 1. Analysis of smoking-related cancer incidence rates in Nevada 2002–2017. Differential
Figure
1. Analysis of smoking-related cancer incidence rates in Nevada 2002–2017. Differential
results demonstrated stable rates of oral cancer incidence (0.0%) with declining rates of esophageal
results
demonstrated stable rates of oral cancer incidence (0.0%) with declining rates of esophageal
cancer incidence (−1.5%) associated mainly with females (−2.5%), as well as declining rates of lung
cancer
incidence (−1.5%) associated mainly with females (−2.5%), as well as declining rates of lung
cancer incidence
3.2%), which
were
most
strongly
associated
with declining
rates among
cancer
incidence(−
(−3.2%),
which
were
most
strongly
associated
with declining
rates males
among males
(−3.9%). Note: insufficient data were available to analyze or plot non-White oral and esophageal
cancer incidence in Nevada.
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An analysis of the overall (national) incidence of these cancers (oral and pharyngeal,
esophageal, lung and bronchus) was compiled to determine if these trends in incidence
within Nevada followed broader national epidemiologic trends (Table 1). These data
demonstrated that trends in the incidence for all cancers were similar between the US
and Nevada (−1.0%, −1.6%, respectively). In addition, the trends in the incidence of oral
cancer were also similar between Nevada and the US overall (0.0%, −0.9%, respectively).
Moreover, the incidence trends among esophageal cancers (−1.5%, −1.1%) and lung
cancers (−3.2%, −2.0%) also demonstrated similar trends between Nevada and the US
overall. It should be noted that insufficient data were available to analyze non-White
(minority) oral and esophageal cancer incidence in Nevada.
Table 1. Comparison of National (US) and Nevada-specific incidence rates of oral and pharyngeal,
esophageal, and lung cancers.

Incidence (all cancer)
(95% Confidence Intervals)
Oral Cancer-Incidence
Race—White (not Hispanic)
Race—Black (plus Hispanic)
Sex—Male
Sex—Female
Esophagus Cancer-Incidence
Race—White (not Hispanic)
Race—Black (plus Hispanic)
Sex—Male
Sex—Female
Lung Cancer-Incidence
Race—White (not Hispanic)
Race—Black (plus Hispanic)
Sex—Male
Sex—Female

Nevada

United States (US)

−1.6%
(−1.9, −1.2)

−1.0%
(−1.2, −0.8)

0.0%
(−0.6, 0.6)
0.6%
(0.0. 1.2)

−0.9%
(−3.8, 2.1)
−0.6%
(−3.7, 2.5)
−1.7%
(−1.9, −1.4)
0.8%
(0.6, 1.0)
0.4%
(0.2, 0.5)

* Insufficient data
0.0%
(−0.7, 0.7)
0.0%
(−1.5, 1.5)

−1.5%
(−2.9, −0.2)
−0.9%
(−2.2, −0.4)
−1.3%
(−2.8, −0.3)
−2.5%
(−4.9, −0.1)

−1.1%
(−1.4, −0.9)
−0.5%
(−0.8, −0.2)
−4.3%
(−4.5, −4.1)
−0.8%
(−1.5, −0.2)
−1.3%
(−1.5, −1.1)

−3.2%
(−3.6, −2.8)
−3.0%
(−3.5, −2.6)
−2.1%
(−3.1, −1.1)
−3.9%
(−4.5, −3.2)
−2.6%
(−3.0, −2.2)

−2.0%
(−2.2, −1.9)
−1.8%
(−2.0, −1.6)
−2.6%
(−3.0, −2.3)
−2.8%
(−2.9, −2.6)
−1.3%
(−1.5, −1.1)

* Insufficient data

* Note: Due to differing state reporting requirements some demographic data may be missing resulting in
“insufficient data”.

Analysis of the epidemiologic data from Nevada revealed an overall decrease in the
rates of cancer mortality (all cancers) of −1.8% (Figure 2). More detailed analysis of these
data stratified by cancer type revealed oral cancer mortality rates in Nevada as declining
(−0.7%) with the majority of these decreases observed among females (−2.2%). In addition,
these data also revealed more significant reductions in the mortality rates of esophageal
cancer in Nevada over this same time period (−1.9%), which also appeared to be most
strongly associated with reductions among females (−1.3%). Finally, reductions were also
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insufficient data were available to analyze non-White (minority) oral and esophageal cancer mortality in Nevada.
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Table 2. Comparison of National (US) and Nevada-specific mortality rates of oral and pharyngeal,
esophageal and lung cancers.

Mortality (all cancer)
(95% Confidence Intervals)
Oral Cancer-Mortality
Race—White (not Hispanic)
Race—Black (plus Hispanic)
Sex—Male
Sex—Female
Esophagus Cancer-Mortality
Race—White (not Hispanic)
Race—Black (plus Hispanic)
Sex—Male
Sex—Female
Lung Cancer-Mortality
Race—White (not Hispanic)
Race—Black (plus Hispanic)
Sex—Male
Sex—Female

Nevada

United States (US)

−1.8%
(−1.9, −1.6)

−1.5%
(−1.6, −1.5)

−0.7%
(−1.0, −0.4)
0.0%
(−0.0. 0.5)

0.5%
(0.1, 1.0)
0.7%
(0.3, 1.0)
−0.3%
(−1.0, 0.4)
0.4%
(0.1, 0.8)
−3.4%
(−9.0, 2.6)

* Insufficient data

−0.1%
(−0.3, 0.3)
−2.2%
(−2.6, −1.6)
−1.9%
(−2.1, −0.2)
0.7%
(0.2, 1.2)

0.3%
(−0.1, 0.7)
−1.3%
(−2.1, −0.5)

−1.2%
(−1.3, −1.0)
−2.2%
(−4.3, −0.1)
−4.6%
(−4.7, −4.4)
−1.1%
(−1.3, −0.9)
−1.5%
(−1.7, −1.4)

−3.1%
(−3.6, −2.8)
−3.2%
(−3.4, −2.8)
−2.7%
(−3.1, −2.4)
−2.6%
(−2.9, −2.3)
−3.1%
(−3.7, −2.6)

−2.4%
(−2.6, −2.3)
−2.5%
(−2.7, −2.2)
−2.6%
(−2.9, −2.4)
−3.1%
(−3.2, −2.9)
−1.8%
(−2.0, −1.6)

* Insufficient data

* Note: Due to differing state reporting requirements some demographic data may be missing resulting in
“insufficient data”.

4. Discussion
The primary objective of this study was to elucidate and evaluate the recent changes to
the epidemiology of both incidence and mortality from oral, as well as esophageal and lung
cancers in Nevada. The results of this current study revealed that oral cancer incidence and
mortality in Nevada is similar with the US overall, a noteworthy development since the last
time these data were analyzed and published [15]. The previous study in 2008 found that
oral cancer incidence and mortality were increasing rapidly in Nevada (approximately 4.6%)
and were the highest in the US—therefore, the results of this current study demonstrate a
dramatic shift to an oral cancer incidence that is now stable (at approximately 0.0%) with
oral cancer mortality declining (−0.7%), which are similar to the national trends. Similar
but more robust declines in the incidence and mortality from esophageal and lung cancer
were also observed in Nevada.
However, the changes in incidence were not equally distributed among all demographic groups—a finding similar to the previous report from nearly a decade ago [14]. The
current study found that although rates of esophageal and lung cancer incidence in Nevada
are decreasing, they are decreasing more rapidly among females in Nevada—supporting
other epidemiologic studies suggesting males nationwide, and especially those in Nevada
may exhibit lowered responses to health prompts and higher resistance to tobacco cessation
efforts and their resulting effects on cancer incidence [18,19]. Similarly, the rates of oral and
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esophageal cancer mortality are also decreasing in Nevada, mainly among females—which
further demonstrates the strong links observed between cancer incidence and mortality [1,5,6]. However, the lack of available data regarding incidence and mortality among
minorities is concerning, given that previous observations have revealed that non-White
(minority) populations may be more vulnerable to, and more likely to suffer from health
disparities in general, and more specifically from smoking-related cancers—such as oral
and pharyngeal, esophageal, and lung cancers [20,21].
The results of this study are significant, as no recent available evidence has evaluated any changes to related smoking-related cancer incidence and mortality in Nevada,
including oral, esophageal, and lung cancers. The original epidemiologic study from this
group in 2008 outlined the increased trend in both oral cancer incidence and mortality in
Nevada, which were the highest in the US at that time [14]. The subsequent follow-up
study analyzing behavioral risk factors such as smoking following the legislative clean
air act (NCIAA) suggested that decreased smoking might subsequently change cancer
incidence and mortality significantly in the intervening decade [15]. This study provides
the first observations of these data and provide detailed analysis of population subgroups,
such as racial and ethnic minorities that are often at greater risk for health disparities
and poor cancer outcomes [22]. These data confirm and support other studies that have
demonstrated changes to behavioral risk factors, such as decreased smoking prevalence,
may be linked with decreases in cancer incidence and subsequent decreases in cancer
mortality [23–25].
Although these data are significant, there are other behavioral and epidemiologic risk
factors besides cigarette use and smoking that contribute to the development, incidence
and mortality of these cancers, such as the influence of alcohol consumption [26]. Although
most epidemiologic studies attribute the majority of oral, esophageal and lung cancer risk
to cigarette and tobacco usage, some significant portion of risk may also be attributable to
other high-risk behavioral patterns, including heavy alcohol use [27]. Because oral cancer
risk may be related significantly, in part, to alcohol consumption and Nevada may be
associated with high rates of alcoholism and heavy drinking—these data and the analysis
of the potential effects of the NCIAA may only partially explain the patterns in cancer
trends observed in this study [28].
5. Conclusions
Previous epidemiologic studies from Nevada found the highest oral cancer incidence
and mortality in the US was observed in Nevada, although subsequent studies following
the NCIAA observed reduced rates of cigarette use following these smoking restrictions and
bans—suggesting that positive changes might subsequently be observed in the incidence
and mortality rates of oral and other related cancers. This study analysis revealed that
oral cancer incidence rates are no longer increasing in Nevada and that mortality rates
have started to decline, although not as rapidly as the overall national rates. However,
rapid decreases in both the incidence and mortality from esophageal and lung cancer were
observed in Nevada, which strongly suggest the corresponding changes in oral cancer may
be part of a larger epidemiologic shift resulting from improved public health policies that
included the NCIAA indoor smoking restrictions and bans.
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